FDA approves ZymoGenetics' Recothrom

FDA approved a BLA from ZymoGenetics (NASDAQ:ZGEN) for Recothrom (formerly rThrombin) recombinant human thrombin as a general aid to achieving hemostasis during surgery. It is the first recombinant, plasma-free thrombin to be approved by the agency (See BioCentury, Jan. 01, 2007). ...